Clinical outcome and safety of periodic infliximab therapy in children and adolescents with Crohn's disease.

Authors :: Diamanti A
Papadatou B
Knafelz D
Gambarara M
Ferretti F
Castro M
Source :: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2004 Sep; Vol. 39 (3), pp. 302-3.
Publication Year :: 2004

Subjects :: Antibodies, Monoclonal adverse effects
Humans
Infliximab
Infusions, Parenteral
Safety
Treatment Outcome
Antibodies, Monoclonal therapeutic use
Crohn Disease therapy

Full Text Access

Tools